from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1522c/mmpL12

LFCtreatmentdescriptionclass of inhibitor

-1.584

Amikacinug/mL Amikacintranslation

-1.298

Cap5-10ug/mL Capreomycintranslation

-1.723

Rox10-50 ug/mL Roxithromycintranslation

-0.253

SM2-5 ug/mL Streptomycintranslation

-2.619

Tet5-10 ug/mL Tetracyclinetranslation

-1.455

Rif0.2-5ug/mL Rifampicintranscription

-0.500

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.315

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.931

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.272

CPZ10-50 ug/mL Chlorpromazinerespiration

0.262

Clofazimine10-13 ug/mL Clofaziminerespiration

0.488

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.252

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.337

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.825

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.801

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.539

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.622

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.281

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.697

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.643

KCN5-20 ug/mL Potassium cyaniderespiration

-0.016

NaN30.2-2 mM Sodium aziderespiration

-0.397

Nigericin50 uM Nigericinrespiration

0.962

TRC10-150 ug/mL Triclosanrespiration

-0.309

TRZ10-25 ug/mL Thioridazinerespiration

0.462

Valinomycin0.5-10 uM Valinomycinrespiration

-2.117

ZnSO42 mM ZnSO4respiration

-0.387

menadione6-10 ug/mL Menadionerespiration

-0.737

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.126

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.783

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.137

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.588

NRP_1Non-replicating persistence stage 1dosRassociated

0.124

Amp0.2mg/mL AmpicillincellWall

0.085

Cephalexin20-100 ug/mL CephalexincellWall

0.029

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.131

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.417

EMB10-20 ug/mL EthambutolcellWall

0.186

Eta12-40 ug/mL EthionamidecellWall

0.115

INH0.2-0.4 ug/mL IsoniazidcellWall

0.634

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.122

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.135

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.261

BZA0.12 mg/mL BenzamidearomaticAmides

1.199

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.128

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.045

H2O24 mM hydrogen peroxideDNAdamaging

-0.137

Levo10 ug/mL LevofloxacinDNAdamaging

0.223

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.330

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.149

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.185

UVUV-irradiationDNAdamaging

-0.599

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.384

Antimycin12.5-50 ug/mL Antimycin A?

-0.211

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.121

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.273

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.155

PA8240.2-2 ug/mL PA-824?

0.364

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.038

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.107

Verapamil50 uM Verapamil?

-0.757

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.227

methoxatin10-20 ug/mL Methoxatin?